Max Healthcare Institute Ltd. (MAXHEALTH) — Tipsheet

Max Healthcare delays Gurgaon hospital, cuts oncology revenue outlook

Tipsheet Editorial — Fri, 22 May 2026 12:22:27 GMT

Management now expects the 500-bed Gurgaon facility by end-FY27, not H1. Oncology's share of revenue is seen stabilising at 21-22%, down from a prior 25-26%.

What’s new

Gurgaon greenfield hospital commissioning delayed by ~6 months to end-FY27.
Oncology revenue mix outlook cut to 21-22% from 25-26% due to CGHS drug pricing.
Brownfield capacity additions of 20%+ remain on track across the network.

Why it matters

The Gurgaon delay is a modest pushback, but the oncology mix revision is structural. It ties directly to a regulatory change (CGHS pricing) that won't reverse, trimming a high-margin segment's contribution to the revenue base. This changes the margin trajectory for the hospital network.

What we’re watching

Whether the ₹1,400 cr Lucknow project faces similar timeline slippage.
Margin impact as lower-margin non-oncology volume makes up the revenue mix.
Execution on the 20%+ brownfield capacity additions this fiscal.

The full read

Max Healthcare's conference call contained two downward revisions. The 500-bed Gurgaon greenfield hospital will now be commissioned by end-FY27, not H1 as previously guided, a six-month delay. More consequentially, management flagged a permanent shift in its oncology revenue mix. The segment will stabilise at 21-22% of revenue, down from a prior 25-26%, due to CGHS drug pricing changes. That's a structural hit to a high-margin business line. The remaining guidance was steady: brownfield additions of 20%+ are on track, and the ₹1,400 crore Lucknow greenfield is progressing on schedule. The oncology revision is the one to watch. CGHS pricing pressure doesn't abate, and it reshapes the revenue mix toward lower-margin general medicine.

Primary source: BSE · NSE

Max Healthcare posts 10% revenue growth, maps ₹1,400 cr Lucknow greenfield hospital

Tipsheet Editorial — Thu, 21 May 2026 16:41:00 GMT

Q4 operating EBITDA up 8% to ₹682 cr; PAT up 3%. Brownfield capacity expansion underway; Kalinga acquisition completed.

What’s new

Board approved ₹1,400 cr greenfield hospital in Lucknow.
Completed acquisition of Kalinga Hospital.
Phased commissioning of ~20% brownfield capacity underway.

Why it matters

Max Healthcare is reinvesting its steady earnings into aggressive capacity expansion. The ₹1,400 cr Lucknow greenfield project and brownfield additions signal confidence in demand, but execution will be key. Margins held steady as top-line grew 10%, giving the company room to fund growth.

What we’re watching

Timeline for Lucknow hospital construction and commissioning.
Occupancy ramp at new brownfield units and Kalinga.
Impact of new competition in Max's key markets.

The full read

Max Healthcare's Q4 earnings were in line with the board-meeting flash: revenue up 10% to ₹2,664 cr, EBITDA up 8% to ₹682 cr, PAT up 3% to ₹387 cr. The fresh news is what Max plans to do with the cash. The board approved a ₹1,400 cr greenfield hospital in Lucknow — the company's first foray into Uttar Pradesh's capital. Separately, the acquisition of Kalinga Hospital has closed, adding beds, and around a fifth of its previously announced brownfield capacity is being commissioned in phases. Max is sustaining its growth while making large forward bets. The market already had the headline numbers; now it has the expansion roadmap.

Primary source: BSE · NSE

Max Healthcare revenue up 16% in FY26, unveils ₹1,400 cr Lucknow hospital

Tipsheet Editorial — Thu, 21 May 2026 16:38:33 GMT

Q4 revenue rose 10% YoY, while full-year growth topped 16%. The company also completed the Kalinga Hospital acquisition and announced a major greenfield project.

What’s new

Detailed Q4 and FY26 results: revenue up 10% and 16% YoY respectively.
₹1,400 crore capex announced for a new hospital in Lucknow.
Acquisition of Kalinga Hospital completed.

Why it matters

Max Healthcare's steady mid-teens growth underscores its strong market position. The new Lucknow project signals aggressive expansion in underpenetrated markets, while the Kalinga acquisition adds bed capacity. All this, however, was already guided—the filing confirms execution, not surprises.

What we’re watching

Timeline for the Lucknow hospital—when does it start contributing?
Integration of Kalinga Hospital: margin impact and bed utilisation.
Any update on the company's debt levels post-capex.

The full read

Max Healthcare's FY26 earnings release confirms a solid year: revenue up 16% to a record high, with Q4 growth of 10% YoY. The numbers were largely pre-disclosed, but the detailed filing adds colour on two strategic moves—the ₹1,400 crore greenfield hospital in Lucknow and the completed acquisition of Kalinga Hospital. Both are part of a stated plan to add capacity in high-demand regions. The filing is more about updating the market on progress than surprising it: growth remains in the mid-teens, capex is substantial but within the company's guided range, and execution looks on track. For a ₹1 lakh crore-plus healthcare major, consistent delivery is the story.

Primary source: BSE · NSE

Max Healthcare to build ₹1,400 cr hospital in Lucknow

Tipsheet Editorial — Thu, 21 May 2026 16:33:20 GMT

The board approved a 712-bed super specialty facility alongside strong FY26 numbers: revenue up 19%, profit up 34%.

What’s new

Approved ₹1,400 cr capex for a 712-bed super specialty hospital in Lucknow.
Consolidated revenue grew 19% YoY to ₹8,373 cr in FY26.
Net profit rose 34% YoY to ₹1,442 cr; ₹2/share dividend declared.

Why it matters

At roughly 17% of annual revenue, the Lucknow investment is one of Max Healthcare's largest greenfield bets. It tests the company's ability to replicate its margin performance in a new geography while expanding capacity. The project's execution — timeline and cost control — will shape the earnings trajectory over the next few years.

What we’re watching

Timeline and cost escalation for the 712-bed Lucknow hospital.
How the capex is funded — internal accruals or debt.
Impact on bed occupancy and margins at existing facilities.

The full read

Max Healthcare's board has approved a ₹1,400 crore greenfield hospital in Lucknow — its biggest single-site bet in recent years. The 712-bed super specialty facility would add roughly 15% to its current bed capacity if completed on schedule. The decision came alongside a strong set of FY26 numbers: revenue climbed 19% to ₹8,373 crore and net profit jumped 34% to ₹1,442 crore, with a ₹2 per share dividend. Routine items such as auditor re-appointment and office shift were also cleared. The capex overshadows the results, raising the question of whether Max Healthcare can maintain its industry-leading margins while executing a project of this scale in a new city. Execution risk is the key variable now.

Primary source: BSE · NSE